DBD
Diebold Nixdorf Incorporated
Delisted
DBD was delisted on the 26th of May, 2023.
164 hedge funds and large institutions have $144M invested in Diebold Nixdorf Incorporated in 2022 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 52 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 28
42% less call options, than puts
Call options by funds: $828K | Put options by funds: $1.42M
Holders
164
Holding in Top 10
2
Calls
$828K
Puts
$1.42M
Top Buyers
| 1 | +$3.51M | |
| 2 | +$1.16M | |
| 3 | +$1.14M | |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$975K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$859K |
Top Sellers
| 1 | -$5.8M | |
| 2 | -$1.88M | |
| 3 | -$1.79M | |
| 4 |
Renaissance Technologies
New York
|
-$1.74M |
| 5 |
GI
GAMCO Investors
Greenwich,
Connecticut
|
-$1.42M |